Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 38,610 · FY2023 14,666 · FY2024 31,235 — 3-yr total 84,511
PSP Pharma LLC is one of Georgia's largest pharmacy chains and pharmaceutical wholesalers, part of PSP Holding (founded 1993). Operates 250+ PSP-branded pharmacies nationwide and an in-house insurance arm (PSP Insurance).
Group parent — controls 1 company · ownership
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 14,282 | 25,917 | 21,848 | 19,994 | 62,962 | 31,482 | 6,194 | 20,831 | +5.5% |
| Net Cash used in Investing Activities | 0 | 35,255 | 14,509 | 11,082 | 12,884 | 14,387 | 17,510 | 964 | -45.1% |
| Free Cash Flow (OCF − Capex proxy) | 14,282 | 9,338 | 7,339 | 8,912 | 50,078 | 17,095 | 11,316 | 19,867 | +4.8% |
| Net Cash from Financing Activities | 0 | 8,136 | 281 | 10,601 | 12,543 | 9,720 | 19,760 | 16,531 | nmf |
| Net Change in Cash (before FX) | 14,282 | 1,202 | 7,620 | 1,689 | 37,535 | 7,375 | 31,076 | 3,336 | -18.8% |
| Effect of FX on Cash | 0 | 491 | 547 | 974 | 707 | 3,793 | 653 | 806 | +8.6% |
| Net Change in Cash (incl. FX) | 14,282 | 1,693 | 7,073 | 715 | 36,828 | 3,582 | 31,729 | 2,530 | -21.9% |
| Cash at Beginning of Year | 0 | 4,811 | 3,118 | 10,191 | 9,476 | 46,304 | 49,886 | 18,157 | +24.8% |
| Cash at End of Year | 0 | 3,118 | 10,191 | 9,476 | 46,304 | 49,886 | 18,157 | 20,687 | +37.1% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →